Clinical Trial Update: Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk [NA]

View source ↗

Summary

This clinical trial is evaluating the efficacy and tolerability of pelvic-prostatic hypofractionated radiotherapy with a boost in men with adverse intermediate-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: To Evaluate the Rate of Digestive and Urinary Toxicity | NA | Status: RECRUITING